\
&
Contact us
Published on | 1 year ago
ProgrammesA total of 2534 proposals were submitted in response to the ERC 2024 Advanced Grant Call (ERC-2024-ADG) with call deadline 29 August 2024. The preliminary data on submitted proposals for each domain is shown below:
Source: European Commission Funding and Tenders Portal
More details on submission statistics are included in the ERCEA news article
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Climate, Energy, Mobility Agro-Food, Environment
Abstract submission and registration are open for the first European Partnership on Animal Health and Welfare Scientific Conference. The event is set to take place in Milan, Italy, from 19 to 22 January 2027 and invites contributions from both EUP AH&W members and non-members. Abstracts are due by 31 August 2026. The conference is designed to... read more
Digital, Industry & Space Agro-Food, Environment
The 2nd EO 4 Soil Symposium is organised by the European Space Agency (ESA) and focusses on three thematic areas: policy and user uptake scientific and technical progress applications and use cases Topics include soil monitoring methods, soil organic carbon mapping, uncertainty assessment, data harmonisation, soil carbon certific... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.